RAC 2.42% $1.61 race oncology ltd

Sheba 2.0 was designed by Borje Anderson. He was at the time...

  1. 18,872 Posts.
    lightbulb Created with Sketch. 5552
    Sheba 2.0 was designed by Borje Anderson. He was at the time Race's CMO and a director of Race.

    It is actually more impressive that bisantrene performed as well as it has hands-off from Race. You don't have to take our word that bisantrene works, you can take the word of a very eminent and independent investigator instead.

    Not that it matters at this point, but the EMD AML trial didn't fail, it was ended by the previous management of RAC for non-clinical reasons. We could start it back up again if we wished, but with the offer of the investigator led trial it doesn't make much sense to spend all our money on running the EMD AML trial when we can get to proof-of-principle in all of AML (not just EMD) for about 1/10th the price.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.61
Change
-0.040(2.42%)
Mkt cap ! $267.8M
Open High Low Value Volume
$1.71 $1.71 $1.54 $370.9K 232.5K

Buyers (Bids)

No. Vol. Price($)
1 392 $1.58
 

Sellers (Offers)

Price($) Vol. No.
$1.61 13999 1
View Market Depth
Last trade - 16.10pm 15/05/2024 (20 minute delay) ?
Last
$1.58
  Change
-0.040 ( 6.08 %)
Open High Low Volume
$1.62 $1.65 $1.54 41933
Last updated 15.58pm 15/05/2024 ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.